Current:Home > ContactNo. 2 House Republican Steve Scalise returns to the Capitol after his blood cancer diagnosis -Secure Horizon Growth
No. 2 House Republican Steve Scalise returns to the Capitol after his blood cancer diagnosis
View
Date:2025-04-17 05:29:04
WASHINGTON (AP) — Rep. Steve Scalise, the No. 2 House Republican, returned to the U.S. Capitol on Thursday for the first time since being diagnosed with a blood cancer known as multiple myeloma and told reporters his chemotherapy treatment is underway.
“It’s kind of a few months process. They don’t know yet how long it’s going to be — four months, six months — but they want to continue to evaluate and say, ‘OK, how’s he doing? How’s the treatment?’ The treatments are going well so far,” said Scalise, who was taking precautions to protect his immune system and wore a face mask and stood back from reporters as he entered the Capitol building.
The Louisiana congressman, 57, said he would be able to receive some of the chemotherapy treatment in Washington and continue his work in Congress, where he was limiting his in-person interactions.
Scalise’s cancer diagnosis comes at a fraught moment for House Republicans, who are trying to avert a government shutdown while also launching an impeachment inquiry into President Joe Biden.
“Obviously there’s a lot going on,” Scalise said. “There always is. But, you know, the main focus is on my health.”
Scalise said his diagnosis came after his wife urged him to visit the doctor three weeks ago when his appetite dropped while he was traveling for political events. He said the diagnosis was made quickly and his wife and he decided they wanted to be “very aggressive” in treating the multiple myeloma.
Scalise was among those wounded in 2017 when a gunman attacked lawmakers at a baseball practice in Alexandria, Virginia. The congressman was shot in the hip and was hospitalized, and he underwent a painful rehabilitation.
veryGood! (661)
Related
- Travis Hunter, the 2
- Netanyahu has sidestepped accountability for failing to prevent Hamas attack, instead blaming others
- 2023 Rockefeller Center Christmas tree has been chosen: See the 80-foot tall Norway Spruce
- Investigators focus on railway inspection practices after fatal Colorado train derailment
- Charges tied to China weigh on GM in Q4, but profit and revenue top expectations
- Director of new Godzilla film pursuing ‘Japanese spirituality’ of 1954 original
- Powerball winning numbers from first drawing of November: Jackpot now at $173 million
- Nigeria’s government budgets for SUVs and president’s wife while millions struggle to make ends meet
- How to watch new prequel series 'Dexter: Original Sin': Premiere date, cast, streaming
- RHOC's Shannon Beador Sentenced to 3 Years Probation, Community Service After DUI Arrest
Ranking
- Former longtime South Carolina congressman John Spratt dies at 82
- Matthew Perry's memoir tops Amazon's best-selling books list days after his passing
- 'Nightmare': How Category 5 Hurricane Otis shocked forecasters and slammed a major city
- California officials confirm 2 cases of dengue, a mosquito-borne illness rarely transmitted in US
- Skins Game to make return to Thanksgiving week with a modern look
- Daylight saving 2023: Here’s what a sleep expert says about the time change
- Florida babysitter who attempted to circumcise 2-year-old boy charged with child abuse
- Missy Elliott, Willie Nelson, Sheryl Crow and Chaka Khan ready for Rock & Roll Hall of Fame
Recommendation
Retirement planning: 3 crucial moves everyone should make before 2025
Arrest made in fatal shooting of Salem State University student
Idaho woman, son charged with kidnapping after police say they took teenager to Oregon for abortion
Oregon man sentenced for LGBTQ+ hate crimes in Idaho, including trying to hit people with car
Federal hiring is about to get the Trump treatment
How the South is trying to win the EV race
Man indicted on conspiracy charge in alleged scheme involving Arizona Medicaid-funded facility
As his minutes pile up, LeBron James continues to fuel Lakers. Will it come at a cost?